MRD Testing in Breast Cancer: ASBrS 2025 Impact ASBrS 3 Mins Read At ASBrS 2025, experts showcased how MRD testing in breast cancer is revolutionizing patient care. Using Natera’s Signatera, clinicians detect circulating tumor…
